BLFS Live signals | Maximize Profits with Getagraph.com

SELL 91747 min ago

@ $18.00

Issued: 14 Feb 2024 @ 09:30

Return: -15.89%

Previous signal: Feb 13 - 09:30

Previous signal: Buy

Return: 5.45 %

Live Chart Being Loaded With Signals

Commentary (17 Apr 2024 @ 16:00):

Stats
Today's Volume	309 106
Average Volume	370 466
Market Cap	685.84M
EPS	$0 ( 2024-02-29 )
Next earnings date	( $-0.260 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-9.96
ATR14	$0.0230 (0.15%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Aebersold Sarah	Sell	4 000	Common Stock
2024-03-27	Mathew Aby J.	Sell	454	Common Stock
2024-03-27	Berard Todd	Sell	515	Common Stock
2024-03-27	Foster Karen A.	Sell	395	Common Stock
2024-03-21	Wichterman Troy	Sell	520	Common Stock

INSIDER POWER
71.82
Last 100 transactions
Buy: 1 176 163 \| Sell: 187 183

Volume Correlation

Long: -0.20 (neutral)

Short: 0.22 (neutral)

Signal:(32.44) Neutral

Biolife Solutions Inc Correlation

10 Most Positive Correlations
COLL	0.888
CTMX	0.873
BCDA	0.867
TNXP	0.85
FPAY	0.849
ANGI	0.847
DADA	0.841
GNSS	0.838
AIP	0.836
ZS	0.836

10 Most Negative Correlations
MASI	-0.882
SWBI	-0.826
AMRB	-0.824
AXON	-0.818
NETE	-0.807
IPAR	-0.806
IBOC	-0.805

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Biolife Solutions Inc Correlation - Currency/Commodity

-0.03
( neutral )

0.46
( neutral )

0.00
( neutral )

-0.37
( neutral )

0.10
( neutral )

0.74
( moderate )

Biolife Solutions Inc Financials

Annual	2023
Revenue:	$143.27M
Gross Profit:	$41.57M (29.02 %)
EPS:	$-1.520

Q4	2023
Revenue:	$32.73M
Gross Profit:	$8.34M (25.47 %)
EPS:	$-0.300

Q3	2023
Revenue:	$33.33M
Gross Profit:	$11.65M (34.95 %)
EPS:	$-0.670

Q2	2023
Revenue:	$39.51M
Gross Profit:	$11.81M (29.90 %)
EPS:	$-0.230

Financial Reports:

No articles found.

Biolife Solutions Inc

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.